Valerie Odegard
2021
In 2021, Valerie Odegard earned a total compensation of $633.6K as President and Chief Scientific Officer at ARS Pharmaceuticals, a 91% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $193,600 |
|---|---|
| Salary | $440,000 |
| Total | $633,600 |
Odegard received $440K in salary, accounting for 69% of the total pay in 2021.
Odegard also received $193.6K in non-equity incentive plan.
Rankings
In 2021, Valerie Odegard's compensation ranked 10,171st out of 12,415 executives tracked by ExecPay. In other words, Odegard earned more than 18.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,171 out of 12,415 | 18th |
Division Manufacturing | 4,499 out of 5,508 | 18th |
Major group Chemicals And Allied Products | 2,008 out of 2,378 | 16th |
Industry group Drugs | 1,781 out of 2,099 | 15th |
Industry Pharmaceutical Preparations | 1,326 out of 1,549 | 14th |
Source: SEC filing on April 28, 2022.
Odegard's colleagues
We found two more compensation records of executives who worked with Valerie Odegard at ARS Pharmaceuticals in 2021.